aspirin has been researched along with prolinedithiocarbamate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adler, G; Liptay, S; Schmid, RM; Wahl, C | 1 |
Feng, J; Liu, Y; Wang, T; Wang, Y; Yang, G; Ye, L; Zhang, X; Zhao, M | 1 |
2 other study(ies) available for aspirin and prolinedithiocarbamate
Article | Year |
---|---|
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Blotting, Western; Cells, Cultured; Colonic Diseases; Cystine; Epithelial Cells; Fluorescent Antibody Technique, Indirect; Humans; Immunosuppression Therapy; Lipopolysaccharides; Mesalamine; NF-kappa B; Phorbol Esters; Phosphorylation; Plasmids; Proline; Recombinant Proteins; Recombination, Genetic; Sulfapyridine; Sulfasalazine; Thiocarbamates; Transcription Factor AP-1; Transfection; Tumor Necrosis Factor-alpha | 1998 |
Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NFκB-ACSL1 signaling.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azo Compounds; Cell Line, Tumor; Cholesterol; Coenzyme A Ligases; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Lipid Droplets; Lipid Metabolism; NF-kappa B; Proline; RNA, Messenger; Signal Transduction; Thiocarbamates; Triglycerides | 2017 |